ELUCIDATE

· On Target Laboratories, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ELUCIDATE, covering 2023-03-23 to 2023-03-23. Get the full timeline:

Most recent: Clinical Trial Update: ELUCIDATE: Enabling Lung Cancer Identification Using Folate Receptor Targeting [Phase 3]